Replies to post #52470 on Rivulet Media Inc (fka RIVU)

[solidgold]

THE NEXT APPROVAL IS FOR CLINICAL TRIAL TO START.

As part of the clinical trial approval process, the FDA will issue comments on the proposed trial which must be addressed to the FDA's satisfaction before patient dosing is initiated. The clinical trial will treat ten patients with aplastic anemia that have not responded to conventional therapy and lack a bone marrow donor.

http://ih.advfn.com/p.php?pid=nmona&article=56788567&symbol=BMSN